Variant · Snv
GFM1 NM_024996.7(GFM1):c.690-5C>G
CI-VAR-00033310Explore in graph →NM_024996.7:c.690-5C>GClinVar 214483 rs201685981
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-24
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260929-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 214483 | Conflicting classifications of pathogenicity | criteria provided, conflicting classifications | 1 | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1; Familial pancreatic carcinoma; Gastric cancer; Lymphoma; Malignant tumor of esophagus; Ovarian serous cystadenocarcinoma; Cervical cancer | germline | 8 | Feb 01, 2026 | clinvar |